Hospitals’ financial positioning is somewhat stable but still under significant pressure, mainly from rising costs and reimbursement issues, according to data released last week by Kaufman Hall. The consulting firm

In life sciences, AI usually makes headlines for drug discovery, molecule design or clinical insights. Behind the scenes, though, the fastest and most repeatable wins are showing up in FDA-oriented

To some, President Donald Trump’s budget proposal might be adding an insult to an injury. Last year, the federal government made significant cuts to healthcare coverage in Medicaid via the

Antibody drug conjugates bring a targeted approach to the treatment of many types of cancer, but there’s still room for improving this class of therapies. This week, two startups revealed

The Department of Justice is taking aim at two large health systems over contracts that the agency says stifle competition and keep patients from receiving affordable care. The lawsuits, both

Many cancer drugs work by blocking proteins associated with tumor progression, but there’s growing industry interest in drugs that eliminate such proteins altogether. Gilead Sciences and Roche have both dipped

Over the years, we’ve seen certain kinds of healthcare costs steadily climb. Administrative expenses at urban hospitals, for example, rose more than 90% between 2011 and 2022, according to government

Chapter, a Medicare navigation platform, announced on Thursday that it raised $100 million in Series E funding. The New York-based company’s AI platform compares health plans from every insurance carrier,

Cell therapy has become an established treatment option for certain blood cancers, but solid tumors remain elusive. Oricell Therapeutics aims to bring cell therapy to solid tumors and it has

The workflow for Social Security disability benefits determination has historically been a slow one, with hospitals and patients often waiting months for records to be requested, collected and manually transferred